Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Gross

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
The Journal of Urology|April 19, 2011
Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way?Thomas Hermanns, Daniel D Strebel, Lukas J Hefermehl, et al.
Clinical Kidney Journal|May 5, 2025
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney diseaseKathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein, et al.
Kidney International Reports|March 19, 2026
Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport SyndromeThomas M Oates, Moumita Barua, Susie Gear, et al.
World Journal of Urology|November 1, 2013
Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry studyThomas Hermanns, Oliver Gross, Benedikt Kranzbühler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 9, 2024
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT AlportOliver Gross, Jan Boeckhaus, Lutz T Weber, et al.
Biomedicines|July 29, 2023
Development of a Sham Protocol to Investigate Transcutaneous Tibial Nerve Stimulation in Randomised, Sham-Controlled, Double-Blind Clinical TrialsStephanie A Stalder, Stéphanie van der Lely, Collene E Anderson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2026
Albuminuria drives hyperlipidemia in patients with Alport syndromeOliver Gross, Annika Jens, Agne Cerkauskaite-Kerpauskiene, et al.
Pediatric Nephrology (Berlin, Germany)|July 13, 2016
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutationsJohanna Stock, Johannes Kuenanz, Niklas Glonke, et al.
Kidney International|June 18, 2004
DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuriaOliver Gross, Bogdan Beirowski, Scott J Harvey, et al.
Pediatric Nephrology (Berlin, Germany)|May 3, 2019
The importance of clinician, patient and researcher collaborations in Alport syndromeMichelle N Rheault, Judith Savige, Michael J Randles, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Urology|April 19, 2011
Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way?Thomas Hermanns, Daniel D Strebel, Lukas J Hefermehl, et al.
Clinical Kidney Journal|May 5, 2025
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney diseaseKathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein, et al.
Kidney International Reports|March 19, 2026
Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport SyndromeThomas M Oates, Moumita Barua, Susie Gear, et al.
World Journal of Urology|November 1, 2013
Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry studyThomas Hermanns, Oliver Gross, Benedikt Kranzbühler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 9, 2024
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT AlportOliver Gross, Jan Boeckhaus, Lutz T Weber, et al.
Biomedicines|July 29, 2023
Development of a Sham Protocol to Investigate Transcutaneous Tibial Nerve Stimulation in Randomised, Sham-Controlled, Double-Blind Clinical TrialsStephanie A Stalder, Stéphanie van der Lely, Collene E Anderson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2026
Albuminuria drives hyperlipidemia in patients with Alport syndromeOliver Gross, Annika Jens, Agne Cerkauskaite-Kerpauskiene, et al.
Pediatric Nephrology (Berlin, Germany)|July 13, 2016
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutationsJohanna Stock, Johannes Kuenanz, Niklas Glonke, et al.
Kidney International|June 18, 2004
DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuriaOliver Gross, Bogdan Beirowski, Scott J Harvey, et al.
Pediatric Nephrology (Berlin, Germany)|May 3, 2019
The importance of clinician, patient and researcher collaborations in Alport syndromeMichelle N Rheault, Judith Savige, Michael J Randles, et al.
Pageof 15